Validation of a Rapid Quantitative Test for Loss of Smell in COVID-19 Subjects

Completed

Conditions studied: COVID-19

In brief

The purpose of this study is to evaluate the performance of a non-invasive olfactory device as a rapid indicator of COVID-19 in positive subjects.

Key facts

Study ID

NCT04431908

Run by

Yale University

People needed

1320

Starts

2020-06-15

Expected to finish

2020-11-18

Last updated by the study team

2021-06-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Provision of signed and dated informed consent form
• Stated willingness to comply with all study procedures and availability for the duration of the study
• Have a corresponding PCR test for SARS-CoV-2 on the same day.

You may not qualify if…

• Adults unable to consent
• Individuals who are not yet adults (infants, children, teenagers)
• Pregnant women
• Individuals with allergic to fragrances
• History of surgery on the nose or paranasal sinuses
• Asthmatics
• Patients with known neurocognitive disorders: dementia, Alzheimer's disease, Parkinson's disease
• Adults with Acute or Chronic rhinosinusitis (They will be asked if they have a 'stuffy or runny nose'; they may be included in some tests, but their analysis would be segregated as they may be false positives due to allergies or a common cold or flu)

Where it is running

• Yale New Haven Hospital — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.